|
ELF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.00000000186662E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72689999999864E-05 |
| Normal-vs-Stage2 |
2.22699999996578E-06 |
| Normal-vs-Stage3 |
1.39870000026576E-07 |
| Normal-vs-Stage4 |
2.07589999967617E-07 |
| Stage1-vs-Stage2 |
6.638100E-02 |
| Stage1-vs-Stage3 |
9.206200E-02 |
| Stage1-vs-Stage4 |
2.556000E-02 |
| Stage2-vs-Stage3 |
5.557000E-01 |
| Stage2-vs-Stage4 |
9.748600E-01 |
| Stage3-vs-Stage4 |
5.436400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.00449999984598E-07 |
| Normal-vs-AfricanAmerican |
7.789700E-02 |
| Normal-vs-Asian |
7.98350000000836E-05 |
| Caucasian-vs-AfricanAmerican |
1.373550E-01 |
| Caucasian-vs-Asian |
7.052600E-01 |
| AfricanAmerican-vs-Asian |
1.617580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.52780000159692E-08 |
| Normal-vs-Female |
7.27420000012913E-07 |
| Male-vs-Female |
1.574580E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.228700E-04 |
| Normal-vs-Age(41-60Yrs) |
7.29169999935664E-08 |
| Normal-vs-Age(61-80Yrs) |
2.43639997066225E-09 |
| Normal-vs-Age(81-100Yrs) |
9.322000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.312000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.655590E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.813400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.285000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.313400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.378200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.879800E-02 |
| Classical-VS-Follicular |
3.672500E-02 |
| Classical-VS-Other |
4.640000E-01 |
| Classical-VS-Normal |
4.98010000005156E-06 |
| Tall-VS-Follicular |
9.366200E-01 |
| Tall-VS-Other |
9.762200E-01 |
| Tall-VS-Normal |
3.4487000000194E-06 |
| Follicular-VS-Other |
9.564400E-01 |
| Follicular-VS-Normal |
1.56640000004149E-06 |
| Other-VS-Normal |
2.557900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64229999599641E-08 |
| Normal-vs-N1 |
4.99939999998311E-06 |
| N0-vs-N1 |
9.198800E-01 |
|
|
